Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00278941
Other study ID # D1448C00005
Secondary ID Amethyst
Status Completed
Phase Phase 3
First received January 17, 2006
Last updated March 24, 2009
Start date December 2005
Est. completion date August 2007

Study information

Verified date March 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine safety & efficacy of SEROQUEL SR™ in the treatment of major depressive disorder compared to placebo & to evaluate quality of sleep, overall quality of life, and effect, if any, on anxiety and satisfaction PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.


Recruitment information / eligibility

Status Completed
Enrollment 3000
Est. completion date August 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Documented clinical diagnosis according to the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision) meeting criteria 296.2x Major Depressive Disorder,

- Single Episode, or 296.3x Major Depressive Disorder,

Exclusion Criteria:

- Patients with a DSM-IV Axis I disorder other than MDD w/in 6 months of enrollment,

- Patients with a diagnosis of DSM-IV Axis II disorder which has a major impact on the patients current psychiatric status.

- Patients whose current episode of depression>12 months or <4 weeks from enrollment

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Intervention

Drug:
Quetiapine Fumarate Sustained Release


Locations

Country Name City State
Bulgaria Research Site Vratza
Canada Research Site Burlington Ontario
Canada Research Site Gatineau Quebec
Canada Research Site Miramichi New Brunswick
Canada Research Site Mississauga Ontario
Canada Research Site Montreal Quebec
Canada Research Site Ottawa Ontario
Canada Research Site Quebec
Canada Research Site Sherbrooke Quebec
Canada Research Site Vancouver British Columbia
Canada Research Site Victoria British Columbia
Puerto Rico Research Site Rio Predia
Romania Research Site Bucharest
Romania Research Site Iasi
Romania Research Site Pitesti
Russian Federation Research Site Moscow
Russian Federation Research Site St Petersburg
Slovakia Research Site Piestany
Slovakia Research Site Presov
Slovakia Research Site Sered
Slovakia Research Site Trencin
United Kingdom Research Site Ayrshire
United Kingdom Research Site Glasgow
United Kingdom Research Site Reading
United States Research Site Allentown Pennsylvania
United States Research Site Altamonte Springs Florida
United States Research Site Anaheim California
United States Research Site Atlanta Georgia
United States Research Site Augusta Georgia
United States Research Site Avon Lake Ohio
United States Research Site Bala Cynwyd Pennsylvania
United States Research Site Baltimore Maryland
United States Research Site Birmingham Alabama
United States Research Site Bloomfield Hills Michigan
United States Research Site Boston Massachusetts
United States Research Site Brooklyn New York
United States Research Site Cambridge Massachusetts
United States Research Site Canton Ohio
United States Research Site Cedarhurst New York
United States Research Site Cerritos California
United States Research Site Chagrin Falls Ohio
United States Research Site Charleston South Carolina
United States Research Site Charlotte North Carolina
United States Research Site Charlottesville Virginia
United States Research Site Cherry Hill New Jersey
United States Research Site Chicago Illinois
United States Research Site Cincinnati Ohio
United States Research Site Clearwater Florida
United States Research Site Cleveland Ohio
United States Research Site Clinton Twp Michigan
United States Research Site Coatesville Pennsylvania
United States Research Site Coeur D'Alene Idaho
United States Research Site Colorado Springs Colorado
United States Research Site Columbus Georgia
United States Research Site Coral Springs Florida
United States Research Site Costa Mesa California
United States Research Site Cromwell Connecticut
United States Research Site Decatur Georgia
United States Research Site DeLand Florida
United States Research Site Desoto Texas
United States Research Site El Centro California
United States Research Site Eugene Oregon
United States Research Site Fall River Massachusetts
United States Research Site Farmington Connecticut
United States Research Site Farmington Hills Michigan
United States Research Site Flowood Mississippi
United States Research Site Fresno California
United States Research Site Friendswood Texas
United States Research Site Ft Myers Florida
United States Research Site Gainsville Florida
United States Research Site Glen Burnie Maryland
United States Research Site Granite City Illinois
United States Research Site Greensboro North Carolina
United States Research Site Greer South Carolina
United States Research Site Havertown Pennsylvania
United States Research Site Hialeah Florida
United States Research Site Hoffman Estates Illinois
United States Research Site Houston Texas
United States Research Site Jacksonville Florida
United States Research Site Jenkintown Pennsylvania
United States Research Site Kenilworth New Jersey
United States Research Site La Mesa California
United States Research Site Lafayette Indiana
United States Research Site Lake Jackson Texas
United States Research Site Las Vegas Nevada
United States Research Site Libertyville Illinois
United States Research Site Lincoln Rhode Island
United States Research Site Little Rock Arkansas
United States Research Site Los Angeles California
United States Research Site Media Pennsylvania
United States Research Site Memphis Tennessee
United States Research Site Mesa Arizona
United States Research Site Miami Florida
United States Research Site Middleburg Heights Ohio
United States Research Site Middletown Connecticut
United States Research Site Midlothian Virginia
United States Research Site Midvale Utah
United States Research Site Milwaukee Wisconsin
United States Research Site Minneapolis Minnesota
United States Research Site Moon Township Pennsylvania
United States Research Site Mount Kisco New York
United States Research Site Nashville Tennessee
United States Research Site New Port Richey Florida
United States Research Site New York New York
United States Research Site North Miami Florida
United States Research Site Northfield Illinois
United States Research Site Ocala Florida
United States Research Site Oceanside California
United States Research Site Oklahoma City Oklahoma
United States Research Site Olean New York
United States Research Site Orlando Florida
United States Research Site Owensboro Kentucky
United States Research Site Palm Beach Gardens Florida
United States Research Site Pasadena California
United States Research Site Peoria Arizona
United States Research Site Pico Rivera California
United States Research Site Pittsburgh Pennsylvania
United States Research Site Pittsfield Massachusetts
United States Research Site Portage Michigan
United States Research Site Prairie Village Kansas
United States Research Site Princeton New Jersey
United States Research Site Providence Rhode Island
United States Research Site Pueblo Colorado
United States Research Site Reading Pennsylvania
United States Research Site Redlands California
United States Research Site Richmond Virginia
United States Research Site Ridgeland Mississippi
United States Research Site Riverside California
United States Research Site Rochester New York
United States Research Site Rochester Hills Michigan
United States Research Site Rockville Maryland
United States Research Site Roswell Georgia
United States Research Site Salem Oregon
United States Research Site San Antonio Texas
United States Research Site San Diego California
United States Research Site Sandy Springs Georgia
United States Research Site Santa Ana California
United States Research Site Sarasota Florida
United States Research Site Shreveport Louisiana
United States Research Site Sioux Falls South Dakota
United States Research Site Skokie Illinois
United States Research Site Spokane Washington
United States Research Site Springfield Massachusetts
United States Research Site St Peters Missouri
United States Research Site St. Charles Missouri
United States Research Site St. Louis Missouri
United States Research Site St. Petersberg Florida
United States Research Site Stanford California
United States Research Site Stuart Florida
United States Research Site Terre Haute Indiana
United States Research Site Toledo Ohio
United States Research Site Toms River New Jersey
United States Research Site Topeka Kansas
United States Research Site Torrance California
United States Research Site Tulsa Oklahoma
United States Research Site Tuscaloosa Alabama
United States Research Site Upland California
United States Research Site Valparaiso Indiana
United States Research Site Virginia Beach Virginia
United States Research Site Vista California
United States Research Site W Palm Beach Florida
United States Research Site Walnut Creek California
United States Research Site Washington District of Columbia
United States Research Site Wichita Falls Texas
United States Research Site Wilmington Delaware
United States Research Site Winston-Salem North Carolina
United States Research Site Woodstock Vermont
United States Research Site Worcester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Countries where clinical trial is conducted

United States,  Bulgaria,  Canada,  Puerto Rico,  Romania,  Russian Federation,  Slovakia,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the efficacy of quetiapine SR compared to placebo in increasing time from randomisation to a depressed event in patients with Major Depressive Disorder (MDD)
Secondary Evaluate quetiapine SR compared to placebo on health related quality of life.
See also
  Status Clinical Trial Phase
Recruiting NCT05537558 - Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
Terminated NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Completed NCT03142919 - Lipopolysaccharide (LPS) Challenge in Depression Phase 2
Recruiting NCT05547035 - Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders N/A
Terminated NCT02940769 - Neurobiological Effects of Light on MDD N/A
Recruiting NCT05892744 - Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression Phase 4
Recruiting NCT05537584 - SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Phase 4
Active, not recruiting NCT05061706 - Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Phase 3
Completed NCT04479852 - A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder Phase 2
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Recruiting NCT05527951 - Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study N/A
Completed NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression Phase 1
Recruiting NCT04392947 - Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation N/A
Recruiting NCT05895747 - 5-HTP and Creatine for Depression R33 Phase Phase 2
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Recruiting NCT05813093 - Interleaved TMS-fMRI in Ultra-treatment Resistant Depression N/A
Recruiting NCT05135897 - The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
Enrolling by invitation NCT04509102 - Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder Early Phase 1
Recruiting NCT06145594 - EMA-Guided Maintenance TMS for Depression N/A
Recruiting NCT06026917 - Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Phase 4